Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Adetayo Odueke

Researcher

Also affiliated: University of Arkansas Medical Center (2025); Washington Regional Medical Center (2025)

Unknown Researcher

2 h-index 8 pubs 23 cited

  • Hypolipidemic Agents
  • Cardiovascular Diseases
  • Heart Disease Risk Factors
  • PCSK9 Inhibitors
  • Dicarboxylic Acids
  • Fatty Acids
  • Humans
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Biography and Research Information

OverviewAI-generated summary

Adetayo Odueke's research focuses on cardiovascular diseases, with recent publications exploring advancements in lipid-lowering therapies and insights into ischemia-reperfusion injury in coronary artery disease. Odueke has investigated strategies for cardiovascular risk reduction, including a narrative review of non-statin lipid therapies. The researcher's work also extends to critical care scenarios, examining outcomes for patients with cardiogenic shock on VA-ECMO and analyzing predictors of adverse cardiovascular events following CAR-T therapy. Additionally, Odueke has contributed to understanding drug safety in specific patient populations, such as the safety of Class 1C antiarrhythmic drugs in patients with arrhythmia-induced cardiomyopathy. Collaborations include work with researchers from the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 2
  • Publications: 8
  • Citations: 23

Selected Publications

  • Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell Therapy: Clinical Characteristics and Impact on Mortality (2026)
    Transplantation and Cellular Therapy DOI OpenAlex
  • TCT-262 Five-Year Mortality Comparison of Left Ventricular Unloading Devices for Individuals with Cardiogenic Shock on VA-ECMO (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction (2025)
    American Journal of Cardiovascular Drugs 2 citations DOI OpenAlex
  • PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
    Journal of the American College of Cardiology DOI OpenAlex
  • Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review (2025)
    Antioxidants 18 citations DOI OpenAlex
  • Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction (2024)
    Circulation DOI OpenAlex
  • A Rapidly Deteriorating Case of Bivalvular Endocarditis in a Hemodialysis Patient: A Case Report (2024)
    Cureus 1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

53 Collaborators 22 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics